Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes

Molecular Immunology

Volumn 48, Issue 1-3, 2010, Pages 294-304

  Zhao, Jiawei ^a   Benakanakere, Manjunatha R ^a   Hosur, Kavita B ^a   Galicia, Johnah C ^a   Martin, Michael ^b   Kinane, Denis F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Human oral keratinocytes; IRF3; JNK; MTOR; NF B; TLR3

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA INTERFERON; I KAPPA B; I KAPPA B KINASE ALPHA; INITIATION FACTOR 4E BINDING PROTEIN 1; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEIN KINASE B; S6 KINASE; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE RELEASE; ENZYME INHIBITION; GINGIVA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA INTERFERENCE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CYTOKINES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON REGULATORY FACTOR-3; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KERATINOCYTES; MITOGEN-ACTIVATED PROTEIN KINASES; MOUTH MUCOSA; POLY I-C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SIROLIMUS; TOLL-LIKE RECEPTOR 3; TOR SERINE-THREONINE KINASES;

MAMMALIA;

EID: 78649511964     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.07.014     Document Type: Article

References (57)

1. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
2. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
3. Ali S.M., Sabatini D.M. Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site. J. Biol. Chem. 2005, 280:19445-19448.
4. Benakanakere M.R., Li Q., Eskan M.A., Singh A.V., Zhao J., Galicia J.C., Stathopoulou P., Knudsen T.B., Kinane D.F. Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J. Biol. Chem. 2009, 284:23107-23115.
5. Benakanakere M.R., Zhao J., Galicia J.C., Martin M., Kinane D.F. Sphingosine kinase-1 is required for toll mediated β-defensin 2 induction in human oral keratinocytes. PLoS ONE 2010, 5:e11512.
6. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004, 430:257-263.
7. Chang S.B., Miron P., Miron A., Iglehart J.D. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells. J. Surg. Res. 2007, 138:37-44.
8. Choo A.Y., Yoon S.O., Kim S.G., Roux P.P., Blenis J. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:17414-17419.
9. Colina R., Costa-Mattioli M., Dowling R.J., Jaramillo M., Tai L.H., Breitbach C.J., Martineau Y., Larsson O., Rong L., Svitkin Y.V., Makrigiannis A.P., Bell J.C., Sonenberg N. Translational control of the innate immune response through IRF-7. Nature 2008, 452:323-328.
10. Dan H.C., Cooper M.J., Cogswell P.C., Duncan J.A., Ting J.P., Baldwin A.S. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev. 2008, 22:1490-1500.
11. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
12. Du K., Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 1998, 273:32377-32379.
13. Eskan M.A., Benakanakere M.R., Rose B.G., Zhang P., Zhao J., Stathopoulou P., Fujioka D., Kinane D.F. Interleukin-1beta modulates proinflammatory cytokine production in human epithelial cells. Infect. Immun. 2008, 76:2080-2089.
14. Eskan M.A., Rose B.G., Benakanakere M.R., Lee M.J., Kinane D.F. Sphingosine 1-phosphate 1 and TLR4 mediate IFN-beta expression in human gingival epithelial cells. J. Immunol. 2008, 180:1818-1825.
15. Ferrari S., Pearson R.B., Siegmann M., Kozma S.C., Thomas G. The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sites. J. Biol. Chem. 1993, 268:16091-16094.
16. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4:491-496.
17. Guertin D.A., Sabatini D.M. The pharmacology of mTOR inhibition. Sci. Signal. 2009, 2:pe24.
18. Guggenheim B., Gmur R., Galicia J.C., Stathopoulou P.G., Benakanakere M.R., Meier A., Thurnheer T., Kinane D.F. In vitro modeling of host-parasite interactions: the 'subgingival' biofilm challenge of primary human epithelial cells. BMC Microbiol. 2009, 9:280.
19. Hidalgo M., Rowinsky E.K. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 2000, 19:6680-6686.
20. Hirata Y., Broquet A.H., Menchen L., Kagnoff M.F. Activation of innate immune defense mechanisms by signaling through RIG-I/IPS-1 in intestinal epithelial cells. J. Immunol. 2007, 179:5425-5432.
21. Inoki K., Ouyang H., Li Y., Guan K.L. Signaling by target of rapamycin proteins in cell growth control. Microbiol. Mol. Biol. Rev. 2005, 69:79-100.
22. Jacinto E., Hall M.N. Tor signalling in bugs, brain and brawn. Nat. Rev. Mol. Cell Biol. 2003, 4:117-126.
23. Jiang Z., Zamanian-Daryoush M., Nie H., Silva A.M., Williams B.R., Li X. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J. Biol. Chem. 2003, 278:16713-16719.
24. Kang D.C., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., Fisher P.B. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:637-642.
25. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e Sousa C., Matsuura Y., Fujita T., Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
26. Kimbrell D.A., Beutler B. The evolution and genetics of innate immunity. Nat. Rev. Genet. 2001, 2:256-267.
27. Kinane D.F., Galicia J.C., Gorr S.U., Stathopoulou P.G., Benakanakere M. P. gingivalis interactions with epithelial cells. Front. Biosci. 2008, 13:966-984.
28. Kinane D.F., Shiba H., Stathopoulou P.G., Zhao H., Lappin D.F., Singh A., Eskan M.A., Beckers S., Waigel S., Alpert B., Knudsen T.B. Gingival epithelial cells heterozygous for Toll-like receptor 4 polymorphisms Asp299Gly and Thr399ile are hypo-responsive to Porphyromonas gingivalis. Genes Immun. 2006, 7:190-200.
29. Kumar A., Zhang J., Yu F.S. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells. Immunology 2006, 117:11-21.
30. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
31. Makela S.M., Strengell M., Pietila T.E., Osterlund P., Julkunen I. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J. Leukoc. Biol. 2009, 85:664-672.
32. Martin M., Rehani K., Jope R.S., Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 2005, 6:777-784.
33. Matsumoto M., Seya T. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv. Drug Deliv. Rev. 2008, 60:805-812.
34. Nave B.T., Ouwens M., Withers D.J., Alessi D.R., Shepherd P.R. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 1999, 344(Pt. 2):427-431.
35. O'Reilly K.E., Rojo F., She Q.B., Solit D., Mills G.B., Smith D., Lane H., Hofmann F., Hicklin D.J., Ludwig D.L., Baselga J., Rosen N. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res. 2006, 66:1500-1508.
36. Ohtani M., Nagai S., Kondo S., Mizuno S., Nakamura K., Tanabe M., Takeuchi T., Matsuda S., Koyasu S. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 2008, 112:635-643.
37. Peltier J., O'Neill A., Schaffer D.V. PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev. Neurobiol. 2007, 67:1348-1361.
38. Pulverer B.J., Kyriakis J.M., Avruch J., Nikolakaki E., Woodgett J.R. Phosphorylation of c-jun mediated by MAP kinases. Nature 1991, 353:670-674.
39. Rehani K., Wang H., Garcia C.A., Kinane D.F., Martin M. Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/2. J. Immunol. 2009, 182:547-553.
40. Rimoldi M., Chieppa M., Salucci V., Avogadri F., Sonzogni A., Sampietro G.M., Nespoli A., Viale G., Allavena P., Rescigno M. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 2005, 6:507-514.
41. Rosenbluth J.M., Mays D.J., Pino M.F., Tang L.J., Pietenpol J.A. A gene signature-based approach identifies mTOR as a regulator of p73. Mol. Cell. Biol. 2008, 28:5951-5964.
42. Sarkar S.N., Peters K.L., Elco C.P., Sakamoto S., Pal S., Sen G.C. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol. 2004, 11:1060-1067.
43. Schmitz F., Heit A., Dreher S., Eisenacher K., Mages J., Haas T., Krug A., Janssen K.P., Kirschning C.J., Wagner H. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur. J. Immunol. 2008, 38:2981-2992.
44. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300:1148-1151.
45. Slots J., Saygun I., Sabeti M., Kubar A. Epstein-Barr virus in oral diseases. J. Periodontal Res. 2006, 41:235-244.
46. Stathopoulou P.G., Benakanakere M.R., Galicia J.C., Kinane D.F. The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol. Immunol. 2009, 24:11-17.
47. Sun S.Y., Rosenberg L.M., Wang X., Zhou Z., Yue P., Fu H., Khuri F.R. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res. 2005, 65:7052-7058.
48. Takahashi N., Yamada T., Narita N., Fujieda S. Double-stranded RNA induces production of RANTES and IL-8 by human nasal fibroblasts. Clin. Immunol. 2006, 118:51-58.
49. Thomson A.W., Turnquist H.R., Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat. Rev. Immunol. 2009, 9:324-337.
50. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
51. Tsuchida T., Kawai T., Akira S. Inhibition of IRF3-dependent antiviral responses by cellular and viral proteins. Cell Res. 2009, 19:3-4.
52. Vercammen E., Staal J., Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin. Microbiol. Rev. 2008, 21:13-25.
53. Weichhart T., Costantino G., Poglitsch M., Rosner M., Zeyda M., Stuhlmeier K.M., Kolbe T., Stulnig T.M., Horl W.H., Hengstschlager M., Muller M., Saemann M.D. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 2008, 29:565-577.
54. Weichhart T., Saemann M.D. The multiple facets of mTOR in immunity. Trends Immunol. 2009, 30:218-226.
55. Wornle M., Sauter M., Kastenmuller K., Ribeiro A., Mussack T., Ladurner R., Sitter T. Role of toll-like receptor 3, RIG-I, and MDA5 in the expression of mesothelial IL-8 induced by viral RNA. Appl. Biochem. Biotechnol. 2010, 160:1179-1187.
56. Wullschleger S., Loewith R., Hall M.N. TOR signaling in growth and metabolism. Cell 2006, 124:471-484.
57. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5:730-737.